F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) is primarily used to detect recurrence or metastatic disease in patients who have negative findings with 131I whole body scan (WBS) and elevated Tg levels [3]. This evidence concerns the gene TG and metastatic neoplasm.